Search

Sartorius Stedim Biotech.

Open

SectorFinance

206.2 1.88

Overview

Share price change

24h

Current

Min

198

Max

203

Key metrics

By Trading Economics

Income

4.9M

93M

Sales

4.2M

766M

P/E

Sector Avg

61.13

21.018

EPS

1.25

Dividend yield

0.37

Profit margin

12.146

Employees

10,477

EBITDA

9.2M

240M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+21.15% upside

Dividends

By Acuity

Dividend yield

Sector Avg

0.37%

4.54%

Next Earnings

22 Oct 2026

Market Stats

By TradingEconomics

Market Cap

370M

18B

Previous open

204.32

Previous close

206.2

News Sentiment

By Acuity

18%

82%

11 / 438 Finance

Sartorius Stedim Biotech. Chart

Past performance is not a reliable indicator of future results.

Related News

21 Sept 2026, 23:52 UTC

News

Boeing Co. has secured two defense contracts worth $41.5 million, while shares have declined slightly in after-market trading, remaining near the lower end of their one-month range.

21 Sept 2026, 23:51 UTC

News

BlackRock Inc. is trading modestly lower in after-market hours, following the launch of its customizable LifePath Solutions target date framework.

21 Sept 2026, 23:50 UTC

News

Northrop Grumman Corp is trading modestly lower in after-market hours, retracing from a peak and positioned below its 20-day moving average.

21 Sept 2026, 23:36 UTC

Correlated Moves
News

The USD/DKK is trading higher as the People's Bank of China maintained its one-year Loan Prime Rate at 3.00%, signaling stable monetary policy.

21 Sept 2026, 23:31 UTC

News

Tapestry Inc is trading modestly higher in after-market hours, with a current market capitalization of $22.56 billion, following three consecutive lower closes.

21 Sept 2026, 23:25 UTC

News

Pentair PLC declared a $0.27 quarterly dividend amid a class action lawsuit alleging securities fraud, with shares modestly lower in after-market trading.

21 Sept 2026, 23:15 UTC

News

TransDigm Group Inc. announced its Extant Aerospace unit will acquire assets for approximately $240 million, driving the stock higher in after-market hours.

21 Sept 2026, 23:15 UTC

News

Baidu Inc faces two class action lawsuits alleging securities fraud, contributing to a slight decline in after-market trading amid ongoing financial concerns.

21 Sept 2026, 23:11 UTC

Social Media
News

Eli Lilly has started construction on a $6.5 billion facility in Houston to produce its GLP-1 receptor agonist, Foundayo, creating over 600 permanent jobs.

21 Sept 2026, 23:11 UTC

Social Media
News

Intel Corp shares advanced during after-market hours, supported by a record-high Nasdaq close and favorable conditions from falling Treasury yields and oil prices.

21 Sept 2026, 23:06 UTC

News

Weyerhaeuser Co announced a $1 million investment in Drayton Valley, Alberta, marking its first Thrive program initiative in Canada, with shares modestly higher in after-market trading.

21 Sept 2026, 23:06 UTC

News
Correlated Moves

Coinbase Global Inc is launching an IPO allocation service for U.S. customers and ceasing sports wagering in Michigan, with shares trading higher in after-market hours.

21 Sept 2026, 23:06 UTC

News

Ethereum's price has advanced sharply to $2.67K, supported by a broader cryptocurrency rally and increased interest from large holders amid positive regulatory developments.

21 Sept 2026, 23:06 UTC

News

Ethereum's price has advanced sharply to $2.67K, supported by regulatory developments and increased interest from large holders amid a broader cryptocurrency rally.

21 Sept 2026, 23:05 UTC

News

Biogen Inc. is trading slightly higher in after-market hours following approvals for at-home LEQEMBI in Japan and China and new Phase 3 data for EMPAVELI.

21 Sept 2026, 23:02 UTC

News
Social Media

GameStop shares rose in after-hours trading as CEO Ryan Cohen disclosed the purchase of 1.15M shares for about $26.4 million, increasing his ownership to 40.5 million.

21 Sept 2026, 23:02 UTC

News

Bitcoin is sharply higher today, reaching its highest level since January, amid a broader cryptocurrency rally and positive U.S.-China trade developments.

21 Sept 2026, 23:02 UTC

News

Bitcoin surged today to its highest level since January, driven by positive U.S.-China trade developments and easing inflation concerns, despite an earlier pullback.

21 Sept 2026, 23:01 UTC

News

Decline in after-market trading after CMS announces potential fee cuts.

21 Sept 2026, 23:01 UTC

News

Thor Industries shares rose in after-market trading following Keystone RV's record sales at the Hershey RV Show, attributed to strong dealer preparation and customer interest.

21 Sept 2026, 23:01 UTC

News

Salesforce Inc shares are advancing in after-market trading following director David Kirk's acquisition of 4.18k shares for approximately $999.5k.

21 Sept 2026, 23:01 UTC

News
Social Media

Vicor Corporation raised its Q3 2026 growth guidance from nearly 10% to over 20%, driving a sharp rise in its share price during after-hours trading.

21 Sept 2026, 23:01 UTC

News

General Motors Co's stock is higher in after-market trading following a $697.7 million contract modification awarded to GM Defense LLC by the U.S. Department of War.

21 Sept 2026, 23:01 UTC

News

DICK'S Sporting Goods Inc faces class action lawsuits over alleged securities fraud, contributing to a modest decline in after-market trading following disappointing earnings.

21 Sept 2026, 23:01 UTC

Macro News
Correlated Moves
News

The U.S. dollar is consolidating against the yen, currently around JPY156.50, with options worth $2.3 billion expiring today.

21 Sept 2026, 23:00 UTC

News

Endava PLC's shares have declined sharply in after-market trading following the appointment of Conor McShane as Interim CFO amid an accounting investigation.

21 Sept 2026, 22:51 UTC

News
Social Media

Robinhood Markets Inc's stock is trading lower after-hours, reversing from a high of $126.41 earlier in the session amid a recovering cryptocurrency market.

21 Sept 2026, 22:01 UTC

News

In after-market trading, Gartner Inc. has moved higher following five consecutive lower daily closes, despite remaining below its 20-day moving average.

21 Sept 2026, 21:01 UTC

News
Event

AnaptysBio reported Q2 net income of $183.88 million and EPS of $5.11, exceeding expectations, leading to a rise in after-market trading.

21 Sept 2026, 20:12 UTC

News
Correlated Moves

NBT Bancorp Inc. is trading higher in after-market hours following the announcement of Kimberly A. Boynton's appointment to its Board of Directors, effective October 1, 2026.

Peer Comparison

Price change

Sartorius Stedim Biotech. Forecast

Price Target

By TipRanks

21.15% upside

12 Months Forecast

Average 240 EUR  21.15%

High 260 EUR

Low 210 EUR

Based on 5 Wall Street analysts offering 12 month price targets forSartorius Stedim Biotech. - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

5 ratings

5

Buy

0

Hold

0

Sell

Sentiment

By Acuity

11 / 438 Finance

News Sentiment

Very Strong Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Sartorius Stedim Biotech.

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, separation, purification, and fluid management services; biolayer interferometry instruments; microbiology enumeration, sterility testing, and air monitoring instruments; pipette products; sensors and analyzers; biomolecule analysis tools; flow cytometry; batch and intensified chromatography systems; lab data and fleet management software; live cell imaging and analysis; surface plasmon resonance solutions; and weighing products. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production; process automation platform and software; and develops and produces transfection, as well as other DNA/RNA delivery reagents and plasmid DNA. It serves manufacturers of medications, vaccines, foods, and chemicals, as well as research and development laboratories. The company was incorporated in 1978 and is headquartered in Aubagne, France. As of December 31, 2023, Sartorius Stedim Biotech S.A. operates as a subsidiary of Sartorius AG.